HLA-A*0201-restricted cytotoxic T-cell epitopes in three PE/PPE family proteins of Mycobacterium tuberculosis

Scandinavian Journal of Immunology

Volumn 67, Issue 4, 2008, Pages 411-417

  Chaitra, M G ^a   Shaila, M S ^a   Chandra, N R ^a   Nayak, R ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; HLA A 0201; HLA A ANTIGEN; PERFORIN; PROTEIN RV1818C; PROTEIN RV3018C; PROTEIN RV3812; UNCLASSIFIED DRUG; EPITOPE; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; T LYMPHOCYTE; TUBERCULOSIS; CHEMISTRY; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; SPECIES DIFFERENCE;

BACTERIAL PROTEINS; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TUBERCULOSIS;

EID: 40849131150     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02078.x     Document Type: Article

References (32)

1. World Health Organization (WHO). Global Tuberculosis Control - Surveillance, Planning, Financing. WHO report 2005 349 P. TB vaccines: progress and problems. Trends Immunol 2001 22 : 160 8.
2. Rodriguez LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculosis meningitis and military tuberculosis: a meta-analysis. Int J Epidemiol 1993 22 : 1154 8.
3. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995 346 : 1339 45.
4. Chadha VK, Suryanarayana L, Suryanarayan HV, Srikantaramu N, Kumar P. Protective effect of BCG among children vaccinated under universal immunization programme. Indian J Pediatr 2004 71 : 1069 74.
5. Stenger S, Mazzaccaro RJ, Uyemura K et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997 276 : 1684 7.
6. Kaleab B, Ottenhoff THM, Converse P, Halapi Genet Tadesse E, Rottenberg M, Kiessling R. Mycobacterial-induced cytotoxic cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Immunol 1990 20 : 369 77.
7. + T cells in vitro. Immunology 1996 87 : 339 42.
8. Geluk A, Taneja V, van Meijgaarden KE et al. Identification of HLA class II-restricted determinants of M. tuberculosis-derived proteins using HLA-transgenic, class II deficient mice. Proc Natl Acad Sci USA 1998 95 : 10797 802.
9. Mehra NK, Jaini R, Rajalingam R, Balamurugan A, Kaur G. Molecular diversity of HLA-A*02 in Asian Indians: predominance of A*0211. Tissue Antigens 2001 57 : 502 7.
10. Cole ST. Learning from the genome sequence of Mycobacterium tuberculosis H37Rv. FEBS Lett 1999 452 : 7 10.
11. Cascioferro A, Delogu G, Colone M et al. PE is a functional domain responsible for protein translocation and localization on mycobacterial cell wall. Mol Microbiol 2007 66 : 1536 47.
12. Balaji KN, Goyal G, Narayana Y, Srinivas M, Chaturvedi R, Mohammad S. Apoptosis triggered by Rv1818c, a PE family gene from Mycobacterium tuberculosis is regulated by mitochondrial intermediates in T cells. Microbes Infect 2007 9 : 271 81.
13. Chaitra MG, Hariharaputran S, Chandra NR, Shaila MS, Nayak R. Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential. Vaccine 2005 23 : 1265 72.
14. Chaitra MG, Shaila MS, Nayak R. Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis. J Med Microbiol 2007 56 : 466 74.
15. Chaitra MG, Nayak R, Shaila MS. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Vaccine 2007 25 : 7168 76.
16. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994 152 : 163 75.
17. Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993 75 : 693 708.
18. Zhou X, Abdel Motal UM, Berg L, Jondal M. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. Eur J Immunol 1992 22 : 3085 90.
19. van der Burg SH, Ras E, Drijfhout JW et al. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells: identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301. Hum Immunol 1995 44 : 189 98.
20. Vonderheide RH, Schultze JL, Anderson KS et al. Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. Cancer Res 2001 61 : 8366 70.
21. Sinnathamby G, Renukaradhya GJ, Rajasekhar M, Nayak R, Shaila MS. Recombinant hemagglutinin protein of rinderpest virus expressed in insect cells induces cytotoxic T-cell responses in cattle. Viral Immunol 2001 14 : 349 58.
22. Kerksiek KM, Pamer EG. T cell responses to bacterial infection. Curr Opin Immunol 1999 11 : 400 5.
23. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993 11 : 129 63.
24. Ladel CH, Daugelat S, Kaufmann SHE. Immune response to Mycobacterium bovis bacille Calmette-Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol 1995 25 : 377 84.
25. + CTL specific for the mycobacterial major secreted antigen 85A. J Immunol 2000 165 : 7088 95.
26. Song CH, Kim HJ, Park JK et al. Depressed Interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun 2000 68 : 4477 84.
27. + T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model. Infect Immun 2003 71 : 1929 37.
28. Wang QM, Sun SH, Hu ZL et al. Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine. Scand J Immunol 2004 60 : 219 25.
29. Caccamo N, Milano S, Di Sano C et al. Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytes. J Infect Dis 2002 186 : 991 8.
30. Mohagheghpour N, Gammon D, Kawamura LM, van Vollenhoven A, Benike CJ, Engleman EG. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol 1998 161 : 2400 6.
31. Klein MR, Hammond AS, Smith SM, Jaye A, Lukey PT, McAdam KP. HLA-B*35-restricted CD8 (+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c. Infect Immun 2002 70 : 981 4.
32. +- cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infect Immun 2004 72 : 2412 5.